STIP1 and neoplasm: Consistently, a peptide fragment in the DP2 domain of STIP1 (peptide 520) disrupted the interaction between STIP1 and HSP90, thus affecting STAT3 signaling and leading to tumor growth inhibition in vitro and in vivo [38].